In the search for new risk factors at the molecular and cellular levels, clinical data [lymph-node involvement (LN) and stage] were used and 104 squamous-cell lung carcinomas were analyzed by immuno-histochemistry for expression of cyclin D1, cyclin A, cdk2, cdk4, RB, and E2F1. The results of the un
Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma
โ Scribed by MiwaAkasofu Imai; Yoshio Oda; Makoto Oda; Isao Nakanishi; Ei Kawahara
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 300 KB
- Volume
- 130
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16 INK4A and/or up-regulation of cyclin D1. In order to assess the frequency and the prognostic value of these abnormalities in NSCLC, immunohisto
Mucin glycoprotein can promote tumor-cell invasion metastasis and modulate the immune recognition of cancer. This study aimed to elucidate the clinical significance of mucin gene overexpression in lung cancer. We collected 60 lung cancer samples and paired non-tumorous lung portions of varying types